Literature DB >> 8509714

Molecular species of lecithins in human gallbladder bile.

D W Hay1, M J Cahalane, N Timofeyeva, M C Carey.   

Abstract

Using a precise high performance liquid chromatography (HPLC) technique, we identified the molecular species of lecithins in gallbladder biles from patients with cholesterol gallstones (n = 29), pigment gallstones (n = 9), morbid obesity (n = 5), and "controls" (n = 10). The major lecithin species identified in all groups, in descending rank order as represented by the fatty acids in the sn-1 and sn-2 positions, were 16:0-18:2, 16:0-18:1, 16:0-20:4, 18:0-18:2, and 18:1-18:2. Lecithin species were found to be more numerous and in substantially different proportions than reported by previous investigators. No significant differences were found between any biliary lecithin species in the cholesterol and pigment stone groups. However, compared with controls, both cholesterol and pigment stone patients had smaller proportions of 16:0-20:4, the principal arachidonyl lecithin species. Using the HPLC elution sequence for quantifying the hydrophilic-hydrophobic balance, we developed a Hydrophobic Index for lecithin species in each bile based upon the principles proposed by D. M. Heuman for bile salt species. Hydrophobic indices of bile salts and lecithin were positively correlated (r = 0.48, R2 = 0.23, P = 0.0002) suggesting that more hydrophobic bile salts were associated with biliary secretion of more hydrophobic lecithins. The most hydrophobic major lecithin species, 18:0-18:2, was present in greater proportions in biles with cholesterol monohydrate crystals in their sediments and in those with cholesterol saturation indices greater than one. This work provides rigorous separation, identification, and quantitation of the lecithin species in human gallbladder bile from a large cohort of patients but, apart from a more hydrophobic bile salt pattern coupling more hydrophobic lecithins, we fail to identify any relationships of biomedical importance between lecithin species and other major biliary constituents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509714

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

1.  Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.

Authors:  Jean F Cuiné; William N Charman; Colin W Pouton; Glenn A Edwards; Christopher J H Porter
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

Review 2.  New insights into the molecular mechanism of intestinal fatty acid absorption.

Authors:  Tony Y Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Eur J Clin Invest       Date:  2013-09-18       Impact factor: 4.686

3.  The effects of dietary phospholipids enriched with phosphatidylethanolamine on bile and red cell membrane lipids in humans.

Authors:  R Pakula; F M Konikoff; M Rubin; Y Ringel; Y Peled; A Tietz; T Gilat
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Hyperhomocysteinemia from trimethylation of hepatic phosphatidylethanolamine during cholesterol cholelithogenesis in inbred mice.

Authors:  Ji Zhang; Diane E Handy; Yufang Wang; Guylaine Bouchard; Jacob Selhub; Joseph Loscalzo; Martin C Carey
Journal:  Hepatology       Date:  2011-06-23       Impact factor: 17.425

Review 5.  Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review.

Authors:  David Q-H Wang; Martin C Carey
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Remodelling of the Vibrio cholerae membrane by incorporation of exogenous fatty acids from host and aquatic environments.

Authors:  David K Giles; Jessica V Hankins; Ziqiang Guan; M Stephen Trent
Journal:  Mol Microbiol       Date:  2010-12-07       Impact factor: 3.501

7.  The incorporation of fatty acids of different chain length into liver and biliary lipids in the perfused rat liver.

Authors:  M Rubin; R Pakula; T Gilat; A Tietz
Journal:  Lipids       Date:  1999-06       Impact factor: 1.880

8.  Prevention of cholesterol cholelithiasis by dietary unsaturated fats in hormone-treated female hamsters.

Authors:  N Ayyad; B I Cohen; A Ohshima; E H Mosbach
Journal:  Lipids       Date:  1996-07       Impact factor: 1.880

9.  Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.

Authors:  Christopher J H Porter; Ann Marie Kaukonen; Ben J Boyd; Glenn A Edwards; William N Charman
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

Review 10.  Supra-molecular association and polymorphic behaviour in systems containing bile acid salts.

Authors:  Marco Calabresi; Patrizia Andreozzi; Camillo La Mesa
Journal:  Molecules       Date:  2007-08-07       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.